Learn more

MICROBIAL CHEM RES FOUND

Overview
  • Total Patents
    2,048
  • GoodIP Patent Rank
    18,242
  • Filing trend
    ⇧ 450.0%
About

MICROBIAL CHEM RES FOUND has a total of 2,048 patent applications. It increased the IP activity by 450.0%. Its first patent ever was published in 1961. It filed its patents most often in Japan, United States and Canada. Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and biotechnology are ZAIDAN HOJIN BISEIBUTSU, MTA KOEZPONTI KEMIAI KUTATO IN and KANTO ISHI PHARMA CO LTD.

Patent filings per year

Chart showing MICROBIAL CHEM RES FOUNDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Umezawa Hamao 889
#2 Takeuchi Tomio 754
#3 Umezawa Sumio 256
#4 Hamada Masa 255
#5 Kondo Shinichi 181
#6 Ishizuka Masaaki 145
#7 Aoyagi Takaaki 123
#8 Osanawa Hiroshi 117
#9 Naganawa Hiroshi 114
#10 Tsuchiya Osamu 108

Latest patents

Publication Filing date Title
WO2020067004A1 Novel virus vector and methods for producing and using same
WO2017141512A1 Catalyst, method for forming amide bond, and method for manufacturing amide compound
MX2018001022A Novel aminoglycoside antibiotic effective against multidrug-resistant bacteria.
US2016362437A1 Method for Producing Lentztrehalose A, Compound Useful for the Method, and Method for Producing the Compound
WO2016190383A1 Novel compound coccoquinone, method for producing same, use of same, and novel microorganism
WO2017060988A1 Method for determining immune status, method for predicting increase in number of cd4+ t cells, method for predicting decrease in number of cd4+ t cells, and kit therefor
WO2016052656A1 Novel compound, method for producing same, and use thereof
WO2016047644A1 Optically active α-trifluormethyl-β-amino acid derivative production method
CN106714802A Cancer cell growth inhibitor, anticancer agent, and method for screening same, as well as novel compound
US2016129035A1 Combined anti-acid-fast bacterial agent, screening method for anti-acid-fast bacterial agents, and activity inhibitor of WecA or ortholog thereof
WO2014132902A1 Novel compound, production method therefor, use of said compound, and novel microorganism
EP3336080A1 Novel compound, production method therefor, and use of said compound
EP2915536A1 Anticancer agent, and combination use anticancer agent
WO2014030597A1 Novel compound and method for producing same, novel microorganism, pharmaceutical composition, and anti-tumor agent
WO2013168820A1 Anti-cxadr antibody
WO2012176909A1 Tripropeptin derivative or pharmacologically acceptable salt thereof, and antibacterial agent
CN103339142A Drug delivery material capable of passing through blood-brain barrier, and peptide and use thereof
EP2620491A1 Microorganism belonging to genus bacillus, thrombolytic enzyme, and method for processing waste
CA2788730A1 Read through inducer, and therapeutic agent for nonsense-mutation-type genetic diseases
WO2011058923A1 Antibacterial agent for drug-resistant bacteria, method for screening for same, and use of same